Generic vs. brand-name cetrorelix for IVF ovarian stimulation
Part of Women’s health & pregnancy clinical trials.
This trial compares a generic version of cetrorelix acetate (a medication used to control ovulation) to the brand-name version during IVF. It aims to see if the generic works just as well for women undergoing ovarian stimulation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in a couple planning to have IVF or ICSI treatment.
- You are a woman under 43 years old.
- You are using a flexible GnRH antagonist protocol (your doctor will explain this).
- You are not planning preimplantation genetic testing (PGT).
- You do not have untreated hydrosalpinges, moderate/severe endometriosis, recurrent miscarriage, or untreated uterine problems.
- You do not have uncontrolled endocrine or other systemic diseases that could affect treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This study compares two ways to prepare the ovaries for egg retrieval before IVF: using a progestin hormone or a GnRH antagonist. The goal is to see which method leads to more successful embryo transfers.
This trial tests a fixed dose of the hormone follitropin delta (Rekovelle) to stimulate the ovaries before intrauterine insemination (IUI). It aims to see if this approach works well for women with regular cycles who are starting IUI for the first time.
This trial tests how well a hormone treatment (hMG) works for people doing IVF with genetic screening of embryos. It may help if you have normal ovarian reserve and are not using donor sperm.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.